FOLH1 and posterior cortical atrophy: Positron emission tomography (PET) using small molecule probes targeting prostate-specific membrane antigen (PSMA PET/CT) is superior to standard of care imaging for detecting regional and distant metastatic recurrent PCa at low PSA levels [26–30], highly specific [30] and reproducible [31].